Article
A $12 Million Lesson In HSR Rule 801.90: Purpose Is The Whole Ballgame
The Federal Trade Commission secured a record $12 million settlement against Edwards Lifesciences and Genesis MedTech for allegedly structuring a medical device acquisition to avoid Hart-Scott-Rodino Act filing requirements. The case centers on whether a $25 million side investment was designed to keep the total transaction price below HSR thresholds, raising critical questions about deal structuring and regulatory compliance.
Bona Law PC
